[1] 杨孜.生物学标记结合临床风险推动子痫前期预测更上一层楼[J]. 中华围产医学杂志, 2011,7: 385-389. [2] Myatt L, Rebecca G,Clifton, et al. First-trimester prediction of preeclampsia in low-risk nulliparous women[J]. Obstet Gynecol, 2012,119(6): 1234-1242. [3] Loire P,Vicaut E,Cruaud P, et al.Limited value of angiogenic factors in obese women[M].Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health,2012:2368-2370. [4] Ghosh SK,Raheja S,Tuli A, et al. Serum placental growth factor as a predictor of early onset preeclampsia in overweight/obese pregnant women[J]. J Am Soc Hypertens, 2013,7(2):137-148. [5] 杨孜.早发型重度先兆子痫-产科医师面临的挑战[J].中国妇产科临床,2003, 4(2) :83-89. [6] 杨孜,王伽略,黄萍,等.重度子痫前期终末器官受累不平行性和围产结局探讨[J].中华围产医学杂志,2006,9:10-14. [7] 杨孜,李蓉,石凌懿,等.早发型重度先兆子痫的临床界定及保守治疗探讨[J].中华妇产科杂志,2005,40:302-305. [8] Ma RQ,Sun MN,Yang Z.Effects of preeclampsia-like symptoms at early gestational stage on feto-placental outcomes in a mouse model[J]. Chin Med J ( Engl), 2010, 123( 6) : 707-712. [9] Theobald GW, Camb MD. Effect of calcium and vitamins a and d on incidence of pregnancy toxaemia[J]. Lancet, 1937,2:1397-1399. [10] Magee LA,Helewa M,Moutquin JM,et al.Diagnosis,evaluation,and management of the hypertensive disorders of pregnancy[J].J Obstet Gynaecol Can,2008,30:S1-48. [11] Visintin C, Mugglestone MA, Almerie MQ, et al.Management of hypertensive disorders during pregnancy:summary of NICE guidance[J].BMJ,2010,340:c2207. [12] Coomarasamy A,Honest H,Papaioannou S,et al.Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review[J]. Obstet Gynecol, 2003,101:1319-1332. [13] Askie LM,Duley L,Henderson-Smart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data[J].Lancet,2007,369: 1791-1798. [14] Bujold E,Roberge S,Lacasse Y,et al.Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy:a meta-analysis[J].Obstet Gynecol,2010,116:402-414. [15] Lowe S,Brown M,Dekker G,et al.Guidelines for the management of hypertensive disorders of pregnancy:australia and new Zealand[J].Aust U Z J Obstet Gyneacol,2009,49:242-246. [16] Poston L, Briley AL, Seed PT, et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial[J]. Lancet,2006,367:1145-1154. [17] Brion LP, Bell EF, Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants[J]. Cochrane Database of Syst Rev, 2003, 3: CD003665. [18] 任淑萍,牛姝,吕乐,等. 过量维生素E摄入对大鼠脂代谢的影响[J].吉林大学学报(医学版),2011,37:61-63. [19] Chappell LC, Seed PT, Briley AL, et al.Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial[J]. Lancet,1999,354:810-816. [20] Vadillo-Ortega F, Perichart-Perera O, Espino S, et al. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled tria[J]. BMJ, 2011,342:d2901. [21] Costantine MM, Cleary K. Eunice kennedy shriver national institute of child health and human development obstetric--fetal pharmacology research units network:pravastatin for the prevention of preeclampsia in high-risk pregnant women[J]. Obstet Gynecol,2013,121:349-353. [22] Cindrova-Davies T, Herrera EA, Niu Y,et al. Reduced cystathionine γ-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator[J]. Am J Pathol, 2013,182: 1448-1458. [23] Bertoia ML, Waring ME, Gupta PS, et al. Implications of new hypertension guidelines in the United States[J]. Hypertension,2012,60:639-644. [24] 史峻梅,杨孜,陈蕾,等.重度子痫前期患者临床发病前预警信息分析[J].中华妇产科杂志,2009,44:337-340. [25] 史峻梅,杨孜,陈蕾,等.重度子痫前期临床警示因素与产前随访时限[J].中国妇幼保健,2009,24:2768-2771. [26] 黄萍, 杨孜, 张 坤,等. 重度子痫前期191例严重并发症的监测[J].中国实用妇科与产科杂志,2006,22:828-831. |